Skip to main content

HEALTH

  • GNC, Discovery partners on get-fit 'Transformation Diaries' Web series

    PITTSBURGH — GNC last week partnered with Discovery Fit & Health on "Transformation Diaries," a custom Web series that follows four women working to achieve their personal "live well" goals. Fitness expert JJ Virgin is serving as the women’s mentor.

  • Lilly, BI diabetes drug shows greater A1C reduction in African-American adults than placebo, study shows

    RIDGEFIELD, Conn. — A drug used to treat Type 2 diabetes produced significant reduction in blood sugar in African-American patients, according to results of a late-stage clinical trial.

    Boehringer Ingelheim Pharmaceuticals and Eli Lilly announced Thursday results of a phase-3 trial of Tradjenta (linagliptin) in which 226 patients with Type 2 diabetes received 5 mg of the drug once per day or placebo.

  • Band-Aid launches Muppet app to take the 'ouch' out of the 'owie'

    SKILLMAN, N.J. — Band-Aid brand adhesive bandages on Wednesday unveiled the Band-Aid Brand Magic Vision app featuring Disney's The Muppets. The one-of-a-kind application and platform employs augmented reality technology to provide parents with an ability to entertain their kids during that moment they get hurt. By downloading the app, parents and children can scan any of the Band-Aid brand adhesive bandages strips and boxes featuring Disney's The Muppets and view any of three distinct adventures and performances from the Muppets.

  • Blood Sugar Basics Game Plan seeks to help Type 2 diabetics better manage condition

    PHILADELPHIA — An interactive user-friendly program that breaks down diabetes management into four goals to help people with Type 2 diabetes better manage their disease has made its debut.

  • FITT Highway Products launches energy shot line in Calif., Nevada convenience stores

    MISSION VIEJO, Calif. — FITT Highway Products on Tuesday announced the initial launch of its F.I.T.T. Energy products — three 2-oz. energy shots — through convenience stores in California and Nevada.

  • Novo Nordisk's Levemir approved for children ages 2 to 5 years

    PRINCETON, N.J. — The Food and Drug Administration has approved a treatment for Type 1 diabetes in children ages 2 to 5 years.

    Drug maker Novo Nordisk announced Tuesday the additional approval of Levemir (insulin detemir [rDNA origin]). The insulin already was approved for Type 1 diabetes in older children and adults and Type 2 diabetes in adults, and the drug maker said the new FDA approval made Levemir the only basal insulin analog for use in the 2 to 5 year age group.

  • Shamrock Farms expands line of milk-based sports nutrition beverages

    PHOENIX — Shamrock Farms on Monday announced the launch of Rockin' Refuel Muscle Builder — a protein beverage made with real milk designed to be low in carbs and high in protein — through GNC locations.

  • Boehringer Ingelheim launches Dulcolax for women

    RIDGEFIELD, Conn. — Boehringer Ingelheim last week announced the launch of Dulcolax Laxative Tablets for Women — tablets that are "comfort-coated" to protect a woman's stomach so the active ingredient, bisacodyl, is released only in the large intestine — to correspond with National Women's Health Week.

X
This ad will auto-close in 10 seconds